More Pediatric Cancer Trials Conducted Due To RACE Act

 
• By Sarah Karlin-Smith

Initial data looks promising as the FDA’s pediatric oncology subcommittee is set to discuss how recent legislative changes have impacted pediatric cancer drug development. 

close up of person's arms holding yellow ribbon
Pediatric cancer trials are getting a boost from the RACE Act. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers